{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:16:22Z","timestamp":1762492582323,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijcha.2021.100782","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:31:30Z","timestamp":1619739090000},"page":"100782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Non-steroidal treatment of cardiac sarcoidosis: A systematic review"],"prefix":"10.1016","volume":"34","author":[{"given":"Cesia","family":"Gallegos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos K.","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridu","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan D.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcha.2021.100782_b0005","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.ijcha.2021.100782_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100782_b0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2021.100782_b0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","article-title":"Clinicopathological study of fatal myocardial sarcoidosis","volume":"278","author":"Matsui","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100782_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1378\/chest.103.1.253","article-title":"Myocardial sarcoidosis","volume":"103","author":"Sharma","year":"1993","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ijcha.2021.100782_b0030","first-page":"220","article-title":"Sarcoidosis in northern Israel; clinical characteristics of 120 patients","volume":"19","author":"Yigla","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.ijcha.2021.100782_b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100782_b0040","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.ijcha.2021.100782_b0045","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100782_b0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.ijcha.2021.100782_b0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"10","key":"10.1016\/j.ijcha.2021.100782_b0060","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ijcha.2021.100782_b0065","doi-asserted-by":"crossref","unstructured":"J. McGowan, M. Sampson, D.M. Salzwedel, E. Cogo, V. Foerster, C. Lefebvre, PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement, J Clin Epidemiol 75 (2016) 40-6.","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"10.1016\/j.ijcha.2021.100782_b0070","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ijcha.2021.100782_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ijcha.2021.100782_b0080","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"key":"10.1016\/j.ijcha.2021.100782_b0085","unstructured":"M.A. Judson, U. Costabel, M. Drent, A. Wells, L. Maier, L. Koth, H. Shigemitsu, D.A. Culver, J. Gelfand, D. Valeyre, N. Sweiss, E. Crouser, A.S. Morgenthau, E.E. Lower, A. Azuma, M. Ishihara, S. Morimoto, T. Tetsuo Yamaguchi, N. Shijubo, J.C. Grutters, M. Rosenbach, H.P. Li, P. Rottoli, Y. Inoue, A. Prasse, R.P. Baughman, T.W. Organ Assessment Instrument Investigators, The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool, Sarcoidosis Vasc Diffuse Lung Dis 31(1) (2014) 19-27."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100782_b0090","doi-asserted-by":"crossref","DOI":"10.17996\/anc.17-00042","article-title":"New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100782_b0095","doi-asserted-by":"crossref","unstructured":"Y. Yazaki, H. Kasai, M. Koshikawa, U. Ikeda, Effect of Additional Methotrexate Use on Clinical Findings and Metabolic Profile in Patients with Cardiac Sarcoidosis, Journal of Cardiac Failure 20(10, Supplement) (2014) S156.","DOI":"10.1016\/j.cardfail.2014.07.148"},{"issue":"suppl_1","key":"10.1016\/j.ijcha.2021.100782_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy565.P1603","article-title":"P1603Efficacy of combination therapy of methotrexate and low-dose corticosteroid for cardiac sarcoidosis evaluated by fuluorine-18 fluorodeoxyglucose positron emission tomography","volume":"39","author":"Yokomatsu","year":"2018","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcha.2021.100782_b0105","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2169\/internalmedicine.53.3120","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern. Med."},{"issue":"18","key":"10.1016\/j.ijcha.2021.100782_b0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2021.100782_b0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2018.11.131","article-title":"Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs","volume":"276","author":"Ballul","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"8\u20139","key":"10.1016\/j.ijcha.2021.100782_b0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100782_b0125","doi-asserted-by":"crossref","first-page":"512A","DOI":"10.1016\/j.chest.2016.08.526","article-title":"Multicenter Experience With Mycophenolate Mofetil in Cardiac Sarcoidosis","volume":"150","author":"Fussner","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ijcha.2021.100782_b0130","doi-asserted-by":"crossref","unstructured":"J.M.C. Griffin, E.; Tandri, H.; Kasper, E. K.; Gilotra, N. A., Combination Therapy with Prednisone and Mycophenolate Mofetil in the Management of Cardiac Sarcoidosis, Journal of Cardiac Failure 24(8) (2018) S101-S102.","DOI":"10.1016\/j.cardfail.2018.07.385"},{"key":"10.1016\/j.ijcha.2021.100782_b0135","unstructured":"M.M. Estephan, M.; Hamblin, M.; Magadan, J., Successful Treatment of Cardiac Sarcoidosis with Biologic and Immunosuppressive Combination Therapy, Arthritis & Rheumatology 67(S10) (2015) 1397."},{"key":"10.1016\/j.ijcha.2021.100782_b0140","unstructured":"R. Kandolin, J. Lehtonen, MIDFIN, 1961Infliximab in cardiac sarcoidosis, European Heart Journal 38(suppl_1) (2017)."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100782_b0145","first-page":"S32","article-title":"Infliximab Stabilizes Ejection Fraction And Reduces Ventricular Tachycardia In Refractory Cardiac Sarcoidosis","volume":"16","author":"Kowlgi","year":"2019","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.ijcha.2021.100782_b0150","first-page":"509","article-title":"Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases","volume":"33","author":"Chapelon-Abric","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ijcha.2021.100782_b0155","doi-asserted-by":"crossref","unstructured":"L.J. Harper, M. McCarthy, M.L. Ribeiro Neto, R. Hachamovitch, K. Pearson, B. Bonanno, J. Shaia, R. Brunken, E. Joyce, D.A. Culver, Infliximab for Refractory Cardiac Sarcoidosis, Am J Cardiol 124(10) (2019) 1630-1635.","DOI":"10.1016\/j.amjcard.2019.07.067"},{"key":"10.1016\/j.ijcha.2021.100782_b0160","doi-asserted-by":"crossref","unstructured":"M.M. Cundiff, D.; Pincus, M.; Campagna, A.; Nghiem, L.; Dou, Y.; Patten, R.; Venesy, D.; Rybicki, M.; Shah, S. P., Treatment of Active Cardiac Sarcoidosis with TNF Alpha Inhibitors, Journal of Cardiac Failure 25 (2019) S27-S28.","DOI":"10.1016\/j.cardfail.2019.07.076"},{"key":"10.1016\/j.ijcha.2021.100782_b0165","doi-asserted-by":"crossref","unstructured":"O.P. Sinokrot, S.; Reyentovich, A.; Addrizzo-Harris, D.J., Efficacy of Infliximab Therapy in Cardiac Sarcoidosis: A Single Center Case Series, Am J Respir Crit Med 199 (2019) A3064.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A3064"},{"key":"10.1016\/j.ijcha.2021.100782_b0170","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0735-1097(20)31413-3","article-title":"Experience with Biologic Agents for the Treatment of Cardiac Sarcoidosis in a U.S. Academic Medical Center","volume":"75","author":"Devraj","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100782_b0175","article-title":"Efficacy and tolerance of TNF alpha inhibitor (TNFI) treatment in cardiac sarcoidosis (CS)","volume":"69","author":"Puyraimond-Zemmour","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ijcha.2021.100782_b0180","article-title":"Role of Alternative Immunosuppressant Therapy in Management of Cardiac Sarcoidosis [abstract]","volume":"71","author":"Injean","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ijcha.2021.100782_b0185","article-title":"Novel Approach to the Treatment of Cardiac Sarcoidosis with TNF-alpha Inhibition [abstract]","volume":"71","author":"Baker","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ijcha.2021.100782_b0190","unstructured":"P. Sethi, D. Rosenthal, J. Zikherman, V. Vedantham, M. Pampaloni, Changes In Global Left Ventricular Ejection Fraction And Myocardial Perfusion By Rb-82 In Patients Treated For Cardiac Sarcoidosis J Nucl Cardiol 25(4) (2018) 1463."},{"key":"10.1016\/j.ijcha.2021.100782_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2020.09.130","article-title":"Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience","author":"Gilotra","year":"2020","journal-title":"J. Card Fail."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100782_b0200","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcha.2021.100782_b0205","first-page":"2","article-title":"Rituximab in Refractory Cardiac Sarcoidosis - Single Center Experience","volume":"68","author":"Krause","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.ijcha.2021.100782_b0210","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100782_b0215","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.23281","article-title":"Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?","volume":"58","author":"Listing","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100782_b0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acr2.11112","article-title":"Treatment of Multiorgan Sarcoidosis With Tofacitinib","volume":"2","author":"Damsky","year":"2020","journal-title":"ACR Open Rheumatol."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100782_b0225","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007408","article-title":"Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis: The Complementary Use of Cardiac Magnetic Resonance Imaging and FDG-PET","volume":"11","author":"Miller","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcha.2021.100782_b0230","article-title":"Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis","author":"Sharp","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcha.2021.100782_b0235","unstructured":"Cardiac Sarcoidosis Randomized Trial, https:\/\/ClinicalTrials.gov\/show\/NCT03593759."},{"key":"10.1016\/j.ijcha.2021.100782_b0240","unstructured":"Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis, https:\/\/ClinicalTrials.gov\/show\/NCT04017936."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100782_b0245","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/joa3.12084","article-title":"Japanese Antibacterial Drug Management for Cardiac Sarcoidosis (J-ACNES): A multicenter, open-label, randomized, controlled study","volume":"34","author":"Ishibashi","year":"2018","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.ijcha.2021.100782_b0250","unstructured":"The Japan Society of Sarcoidosis and Other Granulomatous Disorders, the Diffuse Pulmonary Study Group of the Health and Labor Sciences Research Grant-supported Rare\/Intractable Disease Project, et al. Committee for revision of the diagnostic standard for sarcoidosis. Diagnostic standard and guideline for sarcoidosis - 2006. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 2007; 27: 89 \u2013 102. [In Japanese]"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:11:54Z","timestamp":1762492314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":50,"alternative-id":["S2352906721000701"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100782","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-steroidal treatment of cardiac sarcoidosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100782"}}